ARIA—the median PFS improvement clearly understates the actual benefit given the median happened to be on a scallop on the K-M curves where the two curves were relatively close - the improvement is quite a bit better at say both 45% and 55%.I’ve yet to see an NDA/BLA review where the FDA cares one iota about the median value of a probability distribution.